Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Work In Process (2016 - 2024)

Utah Medical Products (UTMD) has 14 years of Work In Process data on record, last reported at $1.4 million in Q4 2024.

  • For Q4 2024, Work In Process fell 5.92% year-over-year to $1.4 million; the TTM value through Dec 2024 reached $1.4 million, down 5.92%, while the annual FY2024 figure was $1.4 million, 5.92% down from the prior year.
  • Work In Process reached $1.4 million in Q4 2024 per UTMD's latest filing, down from $1.4 million in the prior quarter.
  • Across five years, Work In Process topped out at $1.7 million in Q3 2023 and bottomed at $1.1 million in Q2 2020.
  • Average Work In Process over 5 years is $1.4 million, with a median of $1.4 million recorded in 2020.
  • The widest YoY moves for Work In Process: up 38.23% in 2022, down 14.66% in 2022.
  • A 5-year view of Work In Process shows it stood at $1.4 million in 2020, then rose by 1.67% to $1.4 million in 2021, then fell by 14.66% to $1.2 million in 2022, then grew by 25.98% to $1.5 million in 2023, then dropped by 5.92% to $1.4 million in 2024.
  • Per Business Quant database, its latest 3 readings for Work In Process were $1.4 million in Q4 2024, $1.4 million in Q3 2024, and $1.4 million in Q2 2024.